April 09, 2020: “The U.S. FDA has issued warning letters to three sellers of fraudulent COVID-19 products. There are currently no approved preventatives or...
April 08, 2020 : “Bristol Myers Squibb announced that the U.S. FDA has accepted its supplemental Biologics License Application (sBLA) for Opdivo(nivolumab)plus Yervoy(ipilimumab), administered concomitantly with a limited...
April 09, 2020: “Tiziana Life Sciences (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, announced that...
April 08, 2020: “Avacta Group plc the developer of Affimer® biotherapeutics and reagents, is
pleased to announce that it has entered into a collaboration with Cytiva,
formerly...
April 06, 2020: “A Lancaster University statistician who worked on the first published large randomised clinical trial for a potential treatment for the COVID-19...
Apr 02, 2020: “Novartis announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi® (ruxolitinib) for...
We have reviewed many articles by doing a secondary search in google and found that below-mentioned articles are quite informative and freely available.Please see...